[{"begin": 0, "end": 195, "text": "Reckamp Karen L, Koczywas Marianna, Cristea Mihaela C, Dowell Jonathan E, Wang He-Jing, Gardner Brian K, Milne Ginger L, Figlin Robert A, Fishbein Michael C, Elashoff Robert M, Dubinett Steven M,", "tokenized_text": "Reckamp Karen L , Koczywas Marianna , Cristea Mihaela C , Dowell Jonathan E , Wang He - Jing , Gardner Brian K , Milne Ginger L , Figlin Robert A , Fishbein Michael C , Elashoff Robert M , Dubinett Steven M ,", "type": "authors", "id": 0}, {"begin": 196, "end": 233, "text": "Randomized phase 2 trial of erlotinib", "tokenized_text": "Randomized phase 2 trial of erlotinib", "type": "title", "id": 1}, {"begin": 234, "end": 337, "text": "in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer", "tokenized_text": "in combination with high - dose celecoxib or placebo in patients with advanced non - small cell lung cancer", "type": "title", "id": 2}, {"begin": 339, "end": 345, "text": "Cancer", "tokenized_text": "Cancer", "type": "venue", "id": 3}, {"begin": 347, "end": 351, "text": "2015", "tokenized_text": "2015", "type": "year", "id": 4}]